Skip to content
lifestyle.socialsinsider.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
AlzeCure Pharma
Positive Results From The Phase Ib Clinical Study of NeuroRestore ACD856, Under Development for Alzheimer’s
June 16, 2026
AlzeCure Pharma Enters Into A Collaboration And Out-Licensing Agreement With Lilly For Alzheimer’s Project
June 9, 2026
Notice To Annual General Meeting in AlzeCure Pharma AB
May 30, 2026
AlzeCure Pharma to Host Live Seminar on The Pain Project TrkA-NAM ACD137 with a Focus on Osteoarthritis and Neuropathic Pain
May 30, 2026
AlzeCure Pharma to Present at Redeye Investor Forum Online on May 21
May 29, 2026
AlzeCure Pharma to Present at ABG Investor Days on May 21
May 29, 2026
New scientific Article Published on TrkA-NAM ACD137 Against Osteoarthritic Pain
May 28, 2026
AlzeCure Publishes its Interim Report for January – March 2026
May 27, 2026
Adjusted Timeline for the Previously Communicated Rights Issue
May 27, 2026
Last Patient has Completed AlzeCure’s Phase Ib Clinical Study with NeuroRestore ACD856
May 25, 2026
1
2
Next Page
→